AzTrials
AzTrials

Humeral FractureNCT07645768

Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral Fractures

A study testing Reversed PHILOS Plate and Posterior Double Plate Fixation in people with Humeral Fracture, run by Cairo University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Extra-articular distal-third humeral shaft fractures are difficult to treat because stable fixation must be achieved while minimizing soft-tissue injury and the risk of nerve damage. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Humeral Fracture
What is being tested?
Reversed PHILOS Plate and Posterior Double Plate Fixation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteEgypt
Study dates
1 Dec 2025to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older.
  • Acute extra-articular distal humeral shaft fracture.
  • AO/OTA type 12-A (simple) or 12-B (wedge) fracture.
  • Closed fracture.
  • Isolated injury.
  • Presentation within 14 days of injury.
  • Ability to provide informed consent and comply with follow-up.

Who cannot join

  • Open fractures.
  • Pathological fractures.
  • Previous surgery on the ipsilateral humerus.
  • Polytrauma requiring staged fixation.
  • Contraindication to general anesthesia.
  • Inability to complete the required follow-up period.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Trauma and Orthopedic department, Faculty of Medicine, Cairo University

    Cairo

Other trials in Egypt

About this study

Official title: Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral Fractures: A Randomized Controlled Trial

Extra-articular distal-third humeral shaft fractures are difficult to treat because stable fixation must be achieved while minimizing soft-tissue injury and the risk of nerve damage. Posterior double plating is a commonly used technique but requires extensive surgical exposure and routine handling of the radial and ulnar nerves. Anterior reversed proximal humeral locking plate system (PHILOS) fixation has emerged as a potential alternative that may provide adequate stability with less soft-tissue disruption.

This randomized controlled trial compares anterior reversed PHILOS plating with conventional posterior double plating in adult patients with extra-articular distal-third humeral shaft fractures. The study evaluates functional outcome using the Mayo Elbow Performance Score (MEPS) as primary outcome. Sexondary outcomes include: fracture union, operative parameters, range of motion, and complications including nerve injury, infection, and postoperative stiffness.

Being tested
Reversed PHILOS Plate, Posterior Double Plate Fixation
Medical subject headings
Humeral Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reversed PHILOS PlateDevice

    Fixation of extra-articular distal-third humeral shaft fractures using a reversed proximal humeral internal locking system (PHILOS) plate applied to the anterior surface of the humerus through an anterior approach. The construct was secured with locking screws proximal and distal to the fracture site.

  • Posterior Double Plate FixationDevice

    Fixation of extra-articular distal-third humeral shaft fractures through a posterior approach using orthogonal double plates applied medially and posterolaterally after fracture reduction. Both radial and ulnar nerves were identified and protected during the procedure.

Study groups in NCT07645768
Study groupRoleWhat they receive
Anterior Reversed PHILOS PlatingExperimentalPatients with extra-articular distal-third humeral shaft fractures treated using an anterior approach and fixation with a reversed Proximal Humeral Internal Locking System (PHILOS) plate.
Receives: Device: Reversed PHILOS Plate
Posterior Double PlatingExperimentalPatients with extra-articular distal-third humeral shaft fractures treated using a posterior approach and fixation with orthogonal double plates applied medially and posterolaterally.
Receives: Device: Posterior Double Plate Fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mayo Elbow Performance Score (MEPS)

    pain (45 points), range of motion (20 points), stability (10 points), and daily functional tasks (25 points). Total maximum score is 100 meaning best outcome and total minimum score is 10 indicating worst outcome

    Measured: 24 months after surgery

Secondary outcomes (3)
  1. Operative time

    Measured: Intraoperative

  2. Fracture Union

    Measured: Upto 24 months after surgery

  3. Nerve injury complications

    Measured: Immediately postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2026
  2. Study start1 Dec 2025
  3. Primary completion1 Jun 2026
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned in a 1:1 ratio to undergo either anterior reversed PHILOS plating or conventional posterior double plating for treatment of extra-articular distal-third humeral shaft fractures. Treatment allocation was performed using a computer-generated randomization sequence with allocation concealment through sealed opaque envelopes.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
68 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07645768
Sponsor's protocol ID
N-275-2025
Status last verified
Jun 2026
First submitted
9 Jun 2026
Last updated
12 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Reversed PHILOS Plate and Posterior Double Plate Fixation in people with Humeral Fracture, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mayo Elbow Performance Score (MEPS) (time frame: 24 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in